Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression
Details for Australian Patent Application No. 2002233677 (hide)
International Classifications
Event Publications
27 February 2003 Application Open to Public Inspection
Published as AU-B-2002233677
6 January 2005 Application Accepted
Published as AU-B-2002233677
5 May 2005 Standard Patent Sealed
29 September 2005 Amendment Made
The nature of the amendment is: Amend the invention title to read Method of examining effect of angiogenesis inhibitor mediated by the inhibition of integrin expression
10 May 2007 Assignment Registered
Eisai Co., Ltd. The patent has been assigned to Eisai R&D Management Co., Ltd.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002233676-ANTIBODIES RECOGNIZING HELICOBACTER PYLORI AND METHOD OF DETECTING HELICOBACTER PYLORI
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser